Articles Tagged with ''Biotechnology Innovation Organization''

Bovine plasma donors genetically engineered to produce human antibodies are in the front lines of the struggle against coronavirus.

The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, but the industry is backing the Agriculture Department's push to take over some of FDA's oversight role.

Agriculture Secretary Sonny Perdue has floated the possibility of USDA and the Food and Drug Administration splitting regulatory responsibilities over gene-edited animals.

Dana O’Brien is the executive vice president of food & agriculture at Biotechnology Innovation Organization (BIO) and in this piece he shares his thoughts on improving the regulatory system for animal biotechnology.

The Food and Drug Administration says that a new analysis indicating genome editing in cattle can have unintended consequences underscores the importance of its regulatory approach to animal biotechnology. 

Kristin Peck is the new CEO of Zoetis and Kevin Bailey has left the Senate Ag Committee to join the Glover Park Group.

In a move welcomed by farm and biotech groups but met with wariness by food safety and organic advocates, USDA has decided to take another stab at biotech regulations, withdrawing a proposed rule that mostly pleased no one.